Stock ETNI ENTEST GROUP, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Entest Group, Inc.

Equities

ETNI

US29383T3005

Market Closed - OTC Markets
Other stock markets
 15:26:45 2024-06-25 EDT 		5-day change 1st Jan Change
0.0001 USD 0.00% Intraday chart for Entest Group, Inc. 0.00% 0.00%
2020 Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019 CI
2019 Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019 CI

Highlights

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2019
CI
Entest Group, Inc. Reports Earnings Results for the Full Year Ended August 31, 2019
CI
Entest Group, Inc. Reports Earnings Results for the Third Quarter Ended May 31, 2019
CI
Entest Group, Inc. Reports Earnings Results for the First Quarter Ended November 30, 2018
CI
Peiwen Yu completed the acquisition of 48.3% stake in Entest Group, Inc. from Regen BioPharma, Inc., Bostonia Partners, Inc, Dunhill Ross Partners, Inc., Bio-Technology Partners Business Trust, David Koos and Sherman Family Trust.
CI
Peiwen Yu entered into an agreement to acquire 48.3% stake in Entest Group, Inc. from Regen BioPharma, Inc., Bostonia Partners, Inc, Dunhill Ross Partners, Inc., Bio-Technology Partners Business Trust, David Koos and Sherman Family Trust for $0.33 million.
CI
Entest Biomedical Mulls Acquisitions
CI
Entest Biomedical, Inc. Announces the Research Study Conducted on ImenVax(TM)
CI
Entest Biomedical, Inc. (OTCPK: ENTB) cancelled the acquisition of the assets of Rainbow Veterinary Hospital from Timothy Metzger.
CI
Entest Biomedical, Inc. and RenovoCyte, LLC Updates Progress on 10 Dog Pilot Study of "Universal Donor" Stem Cell Treatment for Canine Osteoarthritis
CI
Entest Biomedical, Inc. cancelled the acquisition of the assets of Titterington Veterinary Services, Inc. from Ron Titterington and Kathy Snell.
CI
Entest Biomedical, Inc. (OTCBB: ENTB) cancelled the acquisition of substantially all assets of Riverdale Animal Hospital, Charlinda Animal Hospital and Culver Pet Clinic from Asaf A. Qadeer.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ETNI Stock
  4. News Entest Group, Inc.
  5. Highlights